Natalie Gukasyan, M.D., medical director, Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medicine, Baltimore.
The treatment of depression has improved dramatically over the last half-century. The introduction of selective serotonin reuptake inhibitors (SSRIs) in…
Copyright © 2021 Bottom Line Inc. 3 Landmark Square Suite 201 Stamford, CT 06901
Bottom Line, Inc. publishes the opinions of expert authorities in many fields These opinions are for educational and illustrative purposes only and should not be considered as either individual advice or as a substitute for legal, accounting, investment, medical and other professional services intended to suit your specific personal needs. Always consult a competent professional for answers specific to your questions and circumstances. Our content is further subject to our Terms and Conditions